The pharmaceutical industry is undergoing considerable changes in face of R&D diminished productivity, the patent cliff and increased competitiveness leading to pricing pressure.
The traditional linear approach to corporate innovation appears unable to increase pipeline value and corporate revenue. In fact, recent mergers and acquisitions, geographic expansion and diversification into consumer and animal healthcare have neither compensated for the slowdown in innovation, nor decreased the unsustainable cost of bringing new drugs to the market.
Big pharma, as a result, is moving…
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Online
Sep 17, 2024
Helsinki (Finland) & Tallinn (Estonia)
Sep 25, 2024
Online
Oct 21, 2024
Online
Menlo Park, CA (USA)
Oct 30, 2024
São Paulo (Brazil)
Frankfurt (Germany)
Nov 14, 2024
Tokyo (Japan)
Mar 20, 2025
Monterey, CA (USA)
![](https://globalventuring.com//content/uploads/2024/07/Leadership-Society-2024-MPU-GIF-600px.gif)